Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Aug 1:13:907249.
doi: 10.3389/fendo.2022.907249. eCollection 2022.

Luteinizing hormone supplementation in women with hypogonadotropic hypogonadism seeking fertility care: Insights from a narrative review

Noemi Di Segni  1   2 , Andrea Busnelli  1   2 , Matteo Secchi  2 , Federico Cirillo  1   2 , Paolo Emanuele Levi-Setti  1   2
Affiliations
Review

Luteinizing hormone supplementation in women with hypogonadotropic hypogonadism seeking fertility care: Insights from a narrative review

Noemi Di Segni et al. Front Endocrinol (Lausanne). .

Abstract

The management of infertile women affected by hypogonadotropic hypogonadism (HH) or conditions mimicking it is particularly challenging. In the present narrative review, we aimed to synthesize the available evidence on the benefit (if any) of exogenous luteinizing hormone (LH) supplementation in this group of patients. Available data support LH supplementation in women with organic or functional HH. On the contrary, the benefit of exogenous LH on reproductive outcomes both in advanced maternal age patients and in cases of depletion of FSH and LH levels induced by GnRH analogues has not been demonstrated. unfortunately, the inhomogeneous study populations as well as the methodological heterogeneity between studies focused on women affected by conditions mimicking HH do not allow reliable conclusions to be drawn.

Keywords: ART; LH; LH supplementation; hypogonadotropic hypogonadism; infertility.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Similar articles

See all similar articles

Cited by

References

    1. Zegers-Hochschild F, Adamson GD, Dyer S, Racowsky C, de Mouzon J, Sokol R, et al. . The international glossary on infertility and fertility care, 2017. Fertil Steril (2017) 108(3):393–406. doi: 10.1016/j.fertnstert.2017.06.005 - DOI - PubMed
    1. Bosch E, Alviggi C, Lispi M, Conforti A, Hanyaloglu AC, Chuderland D, et al. . Reduced FSH and LH action: Implications for medically assisted reproduction. Hum Reprod (2021) 36(6):1469–80. doi: 10.1093/humrep/deab065 - DOI - PMC - PubMed
    1. Fraietta R, Zylberstejn DS, Esteves SC. Hypogonadotropic hypogonadism revisited. Clinics (Sao Paulo). (2013) 68 Suppl 1:81–8. doi: 10.6061/clinics/2013(Sup01)09 - DOI - PMC - PubMed
    1. Bianco SD, Kaiser UB. The genetic and molecular basis of idiopathic hypogonadotropic hypogonadism. Nat Rev Endocrinol (2009) 5(10):569–76. doi: 10.1038/nrendo.2009.177 - DOI - PMC - PubMed
    1. Wide L, Eriksson K. Low-glycosylated forms of both FSH and LH play major roles in the natural ovarian stimulation. Ups J Med Sci (2018) 123(2):100–8. doi: 10.1080/03009734.2018.1467983 - DOI - PMC - PubMed

Substances